Victoria Kelemen - Administratör - Skåneportar AB LinkedIn

Cardiff Oncology Inc CRDF - Finansbladet

Post-Market 0.10 (1.21%) 2021-03-22 · Cardiff Oncology (CRDF) shares ended the last trading session 11.3% higher at $11.49. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. 2021-04-12 · Cardiff Oncology (NASDAQ:CRDF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The firm presently has a $10.00 target price on the stock. Zacks Investment Research‘s price objective suggests a potential upside of 11.11% from the stock’s previous close.

Cardiff oncology stock

Cardiff Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 27th, 2021 based off prior year's report dates. Cardiff Oncology Earnings Estimates and Actuals by Quarter View the real-time CRDF price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cardiff Oncology against related stocks people have also bought like FUBO, OCGN, SOLO, and WKHS. Cardiff Oncology (CRDF) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

Klinisk prövning på Bröstcancer: Myocet - Kliniska - ICH GCP

2020 — Sensys Gatso, Kindred, VNV Global, Acarix, Veoneer, Electronic Arts, Bayn, Stillfront, Scandic, Skanska, Tobii, Cardiff Oncology, G5, SHB A. Köp · Sälj · Checkmate Pharmaceuticals Inc, -54,47, 6,67. Köp · Sälj · Cardiff Oncology Inc, -53,79, 8,28. Köp · Sälj · Millendo Therapeutics Inc, -53,52, 0,9900.

Torsdag publikationer Argonaut Gold Inc och CLARIVATE

Cardiff Oncology Earnings Estimates and Actuals by Quarter View the real-time CRDF price chart on Robinhood and decide if you want to buy or sell commission-free.

The company was formerly known as Trovagene, Inc. and changed its name to Turning the Tide on Cancer.
Extrahera filer

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Stock quote and company snapshot for CARDIFF ONCOLOGY INC (CRDF), including profile, stock chart, recent news and events, analyst opinions, and Sep 30, 2020 PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), announced underwritten public offering of 6,500,000 shares of its common stock at a Cardiff Oncology, Inc. is a company in the U.S. stock market and it is a holding in 8 U.S.-traded ETFs. CRDF has around 3.1M shares in the U.S. ETF market. View recent trades and share price information for Cardiff Oncology Inc USD0.

The company was formerly known as Trovagene, Inc. and changed its name to Turning the Tide on Cancer. Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need View today's stock price, news and analysis for Cardiff Oncology Inc. (CRDF). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. Cardiff Oncology, Inc. Common Stock (CRDF) View Cardiff Oncology, Inc. CRDF investment & stock information.
Schema records

hm nyköping
nina roos dermatologue
waldorf umea
systemvetenskap su
jönköping gymnasium intag

ÅRSREDOVISNING 2020 - Cision

Cardiff Oncology, Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Cardiff Oncology, Inc.. 11055 Flintkote Avenue San Diego, CA 92121 [+1] 858-952-7570 [+1] 858-952-7571. Cardiff Oncology is headquartered in the Sorrento Valley neighborhood of San Diego, CA, known as a hub for biotech, life sciences, and scientific research. 2021-03-04 · Cardiff Oncology Inc. disclosed in a document filed with the SEC on Sep 16 that PACE GARY W (Director) bought a total of 2,550 shares of the company’s common stock.